West Pharmaceutical Services, Inc. manufactures and sells containment and delivery systems for injectable drugs and healthcare products in the United States, Germany, France, Other European countries, and internationally. The company operates through two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, and washing and sterilization processes and services to enhance the quality of packaging components. It also provides drug containment solutions, including CZ, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as specialized testing services for drug packaging, devices, and administration systems. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. This segment serves pharmaceutical, diagnostic, and medical device companies. The company distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.
Industry, Sector and Symbol
Stock Exchange NYSE
Industry Fabricated rubber products, not elsewhere classified
Sub-IndustryHealth Care Supplies
SectorMedical
Current SymbolNYSE:WST
Previous Symbol
CUSIP95530610
Phone610-594-2900
Debt
Debt-to-Equity Ratio0.15
Current Ratio2.94
Quick Ratio2.23
Price-To-Earnings
Trailing P/E Ratio38.71
Forward P/E Ratio38.03
P/E Growth3.97
Sales & Book Value
Annual Sales$1.60 billion
Price / Sales4.99
Cash Flow$4.2006 per share
Price / Cash Flow25.62
Book Value$17.24 per share
Price / Book6.24
Profitability
EPS (Most Recent Fiscal Year)$2.78
Net Income$150.70 million
Net Margins9.06%
Return on Equity15.78%
Return on Assets10.90%
Miscellaneous
Employees7,500
Outstanding Shares74,080,000
Market Cap$7.85 billion
OptionableOptionable
West Pharmaceutical Services (NYSE:WST) Frequently Asked Questions
What is West Pharmaceutical Services' stock symbol?
West Pharmaceutical Services trades on the New York Stock Exchange (NYSE) under the ticker symbol "WST."
How often does West Pharmaceutical Services pay dividends? What is the dividend yield for West Pharmaceutical Services?
West Pharmaceutical Services declared a quarterly dividend on Thursday, May 3rd. Shareholders of record on Wednesday, October 24th will be paid a dividend of $0.15 per share on Wednesday, November 7th. This represents a $0.60 annualized dividend and a yield of 0.56%. The ex-dividend date of this dividend is Tuesday, October 23rd. This is a boost from West Pharmaceutical Services's previous quarterly dividend of $0.14. View West Pharmaceutical Services' Dividend History.
How will West Pharmaceutical Services' stock buyback program work?
West Pharmaceutical Services announced that its board has initiated a share buyback plan on Thursday, February 15th 2018, which permits the company to repurchase 800,000 outstanding shares, according to EventVestor. This repurchase authorization permits the company to repurchase shares of its stock through open market purchases. Shares repurchase plans are typically an indication that the company's leadership believes its stock is undervalued.
How were West Pharmaceutical Services' earnings last quarter?
West Pharmaceutical Services Inc. (NYSE:WST) posted its quarterly earnings data on Thursday, October, 25th. The medical instruments supplier reported $0.76 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.70 by $0.06. The medical instruments supplier earned $431.70 million during the quarter, compared to analyst estimates of $427.55 million. West Pharmaceutical Services had a net margin of 9.06% and a return on equity of 15.78%. View West Pharmaceutical Services' Earnings History.
When is West Pharmaceutical Services' next earnings date?
What guidance has West Pharmaceutical Services issued on next quarter's earnings?
West Pharmaceutical Services updated its FY 2018 earnings guidance on Thursday, October, 25th. The company provided EPS guidance of $2.80-2.90 for the period, compared to the Thomson Reuters consensus EPS estimate of $2.82. The company issued revenue guidance of $1.72-1.73 billion, compared to the consensus revenue estimate of $1.73 billion.
What price target have analysts set for WST?
2 analysts have issued 12-month target prices for West Pharmaceutical Services' stock. Their forecasts range from $85.00 to $110.00. On average, they anticipate West Pharmaceutical Services' share price to reach $97.50 in the next year. This suggests that the stock has a possible downside of 9.4%. View Analyst Price Targets for West Pharmaceutical Services.
What is the consensus analysts' recommendation for West Pharmaceutical Services?
2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for West Pharmaceutical Services in the last year. There are currently 1 sell rating and 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for West Pharmaceutical Services.
Has West Pharmaceutical Services been receiving favorable news coverage?
Headlines about WST stock have trended somewhat positive this week, according to InfoTrie Sentiment Analysis. The research firm rates the sentiment of news coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. West Pharmaceutical Services earned a media sentiment score of 1.9 on InfoTrie's scale. They also gave media stories about the medical instruments supplier a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an effect on the stock's share price in the near term.
Who are some of West Pharmaceutical Services' key competitors?
Some companies that are related to West Pharmaceutical Services include Actelion (ALIOF), ASTELLAS PHARMA/ADR (ALPMY), Centene (CNC), ESSILOR Intl S/S (ESLOY), Takeda Pharmaceutical (TKPYY), Alexion Pharmaceuticals (ALXN), Eisai (ESALY), FRESENIUS SE &/S (FSNUY), McKesson (MCK), LONZA GRP AG/ADR (LZAGY), Zimmer Biomet (ZBH), Fresenius Medical Care AG & Co. (FMS), TERUMO CORP/ADR (TRUMY), Teva Pharmaceutical Industries (TEVA) and COLOPLAST A/S/ADR (CLPBY).
Who are West Pharmaceutical Services' key executives?
West Pharmaceutical Services' management team includes the folowing people:
- Mr. Eric M. Green, CEO, Pres & Director (Age 48)
- Mr. George Lloyd Miller, Sr. VP, Gen. Counsel & Corp. Sec. (Age 63)
- Ms. Annette F. Favorite, Chief HR Officer and Sr. VP (Age 53)
- Ms. Karen A. Flynn, Chief Commercial Officer & Sr. VP (Age 55)
- Mr. William J. Federici, Advisor (Age 58)
Who are West Pharmaceutical Services' major shareholders?
West Pharmaceutical Services' stock is owned by many different of institutional and retail investors. Top institutional investors include Vanguard Group Inc. (9.54%), BlackRock Inc. (8.96%), Franklin Resources Inc. (6.53%), Neuberger Berman Group LLC (3.92%), Alliancebernstein L.P. (2.96%) and JPMorgan Chase & Co. (2.21%). Company insiders that own West Pharmaceutical Services stock include Daniel Malone, Karen Flynn, Patrick J Zenner and William J Federici. View Institutional Ownership Trends for West Pharmaceutical Services.
Which major investors are selling West Pharmaceutical Services stock?
WST stock was sold by a variety of institutional investors in the last quarter, including Alliancebernstein L.P., JPMorgan Chase & Co., William Blair Investment Management LLC, Schroder Investment Management Group, Neuberger Berman Group LLC, Eagle Asset Management Inc., Victory Capital Management Inc. and Renaissance Technologies LLC. Company insiders that have sold West Pharmaceutical Services company stock in the last year include Daniel Malone, Karen Flynn and William J Federici. View Insider Buying and Selling for West Pharmaceutical Services.
Which major investors are buying West Pharmaceutical Services stock?
WST stock was bought by a variety of institutional investors in the last quarter, including WCM Investment Management CA, Massachusetts Financial Services Co. MA, Kornitzer Capital Management Inc. KS, Riverbridge Partners LLC, Morgan Stanley, Vanguard Group Inc., Prudential Financial Inc. and Franklin Resources Inc.. View Insider Buying and Selling for West Pharmaceutical Services.
How do I buy shares of West Pharmaceutical Services?
Shares of WST can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is West Pharmaceutical Services' stock price today?
One share of WST stock can currently be purchased for approximately $107.62.
How big of a company is West Pharmaceutical Services?
West Pharmaceutical Services has a market capitalization of $7.85 billion and generates $1.60 billion in revenue each year. The medical instruments supplier earns $150.70 million in net income (profit) each year or $2.78 on an earnings per share basis. West Pharmaceutical Services employs 7,500 workers across the globe.
What is West Pharmaceutical Services' official website?
How can I contact West Pharmaceutical Services?
West Pharmaceutical Services' mailing address is 530 HERMAN O. WEST DRIVE, EXTON PA, 19341. The medical instruments supplier can be reached via phone at 610-594-2900 or via email at [email protected]
MarketBeat Community Rating for West Pharmaceutical Services (NYSE WST)
MarketBeat's community ratings are surveys of what our community members think about West Pharmaceutical Services and other stocks. Vote "Outperform" if you believe WST will outperform the S&P 500 over the long term. Vote "Underperform" if you believe WST will underperform the S&P 500 over the long term. You may vote once every thirty days.
